Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
---|
04/07/2005 | US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
04/07/2005 | US20050074895 analysis of protein expression by the reaction of proteins with alkyl-substituted vinyl pyridines as thiol alkylating agents; mass difference is considerably greater than that achieved by isotope tagging |
04/07/2005 | US20050074815 Bioassays incorporate film with chemiluminescent precursor immobilized therewith; polynucleotide/DNA analysis; kits |
04/07/2005 | US20050074794 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples |
03/31/2005 | WO2005028665A2 Campylobacter polypeptides and methods of use |
03/31/2005 | WO2005028664A2 Modulation of programmed necrosis |
03/31/2005 | WO2005028663A2 Operator independent programmable sample preparation and analysis system |
03/31/2005 | WO2005007874A3 Sequential generation of multiple chemiluminescent signals on solid supports |
03/31/2005 | WO2004104213A3 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof |
03/31/2005 | WO2004092394A3 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof |
03/31/2005 | WO2004076677A3 Monoclonal antibody production by ebv transformation of b cells |
03/31/2005 | WO2004048598A3 Molecular nephrotoxicology modeling |
03/31/2005 | US20050071087 Systems and methods for detecting biological features |
03/31/2005 | US20050069908 DNA polymerase compositions for quantitative PCR and methods thereof |
03/31/2005 | CA2539108A1 Operator independent programmable sample preparation and analysis system |
03/31/2005 | CA2539074A1 Campylobacter polypeptides and methods of use |
03/29/2005 | CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
03/24/2005 | WO2005026381A2 Microarray analysis of host and pathogen gene expression changes in vivo |
03/24/2005 | WO2005026380A2 Bone marrow proliferation assay |
03/24/2005 | WO2005026379A2 The mapping and reconstitution of a conformational discontinuous binding surface |
03/24/2005 | WO2005026375A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
03/24/2005 | WO2005010201A3 Methods and compositions for detecting nucleic acid sequences |
03/24/2005 | WO2004111259A3 Hydrolytic substrates for an analyte-dependent enzyme activation system |
03/24/2005 | WO2004097030A3 Prognostic breast cancer biomarkers |
03/24/2005 | WO2004083450A3 Hyperbranched dendron and methods of synthesis and use thereof |
03/24/2005 | US20050064531 Methods for screening and identifying compounds |
03/24/2005 | US20050064476 Methods for identifying DNA copy number changes |
03/24/2005 | US20050064426 Utilizing probe dependent coefficients to re-scale and correct hybridization data; enhancing accuracy of measured gene expression levels |
03/24/2005 | US20050064394 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
03/24/2005 | US20050063441 High density methods for producing diode-pumped micro lasers |
03/24/2005 | US20050062196 Microfluidic protein crystallography techniques |
03/24/2005 | CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
03/22/2005 | US6870047 Magnetic pigment |
03/17/2005 | WO2005024046A2 Methods of detection and notification of bioagent contamination |
03/17/2005 | WO2005024045A2 Primers for use in detecting beta-lactamases |
03/17/2005 | WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk |
03/17/2005 | WO2005024043A2 Methods for identifying, diagnosing, and predicting survival of lymphomas |
03/17/2005 | WO2005024042A2 Aptamers and methods for their in vitro selection and uses thereof |
03/17/2005 | WO2005024041A2 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins |
03/17/2005 | WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25 |
03/17/2005 | WO2005012543A3 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
03/17/2005 | WO2005003369A3 Methods for detection and quantification of analytes |
03/17/2005 | WO2004092399A3 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism |
03/17/2005 | US20050059632 Synthesis of beta-L-2'-deoxy nucleosides |
03/17/2005 | US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
03/17/2005 | US20050059018 Virulence-associated nucleic acids and proteins and uses thereof |
03/17/2005 | CA2538270A1 Primers for use in detecting beta-lactamases |
03/17/2005 | CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk |
03/17/2005 | CA2537254A1 Methods for identifying, diagnosing, and predicting survival of lymphomas |
03/16/2005 | EP1513956A2 Assay to detect replication competent viruses |
03/16/2005 | EP1366360A4 Methods for large scale protein matching |
03/16/2005 | CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
03/10/2005 | WO2005021778A2 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |
03/10/2005 | WO2005021777A2 Uses of spatial configuration to modulate protein function |
03/10/2005 | WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
03/10/2005 | WO2005021775A2 Method for identifying selective growth inhibitors |
03/10/2005 | WO2004072294A3 Methods and means for nucleic acid sequencing |
03/10/2005 | WO2004057017A3 Detection of small nucleic acids |
03/10/2005 | US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders |
03/10/2005 | CA2536621A1 Method for identifying selective growth inhibitors |
03/10/2005 | CA2535902A1 Uses of spatial configuration to modulate protein function |
03/09/2005 | CN1590551A Optimization of cell for endogenous gene activation |
03/03/2005 | WO2005019471A2 Periostin-like factor: compositions and methods for making and using the same |
03/03/2005 | WO2005019470A2 Detecting and profiling molecular complexes |
03/03/2005 | WO2005005652A3 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants |
03/03/2005 | WO2004104211A3 Method for detecting toxic and non-toxic cyanobacteria |
03/03/2005 | US20050050588 Phloem small RNA binding protein (PSRB) for use in enhancing plant growth, systemic resistance, biomass distribution and flowering |
03/03/2005 | US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders |
03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
03/03/2005 | CA2535510A1 Detecting and profiling molecular complexes |
03/02/2005 | EP1510823A2 Containers for performing polymerase chain reaction |
03/02/2005 | EP1509768A2 Methods for cohort selection and longevity studies |
03/02/2005 | EP1509226A2 Small molecule inhibitors of her2 expression |
02/24/2005 | WO2005017190A2 Mitotic kinesin inhibitors |
02/24/2005 | WO2005017187A2 Methods for screening and identifying compounds |
02/24/2005 | WO2005017186A2 Method for rapid identification of alternative splicing |
02/24/2005 | WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS |
02/24/2005 | WO2005017183A2 Methylated gene biomarkers for detecting cancer |
02/24/2005 | WO2005017182A2 Multi-color in vitro translation |
02/24/2005 | WO2005017180A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
02/24/2005 | WO2005017176A2 Methods for identifying risk of melanoma and treatments thereof |
02/24/2005 | WO2004070053A3 cDNA AMPLIFICATION FOR EXPRESSION PROFILING |
02/24/2005 | WO2004070051A3 Chemical proteomics |
02/24/2005 | WO2004055196A3 Method for identifying risk of breast cancer and treatments thereof |
02/24/2005 | WO2004049914A3 Methods for reacting an antigen masking compound with red blood cells with high efficiency |
02/24/2005 | US20050043597 Optical vivo probe of analyte concentration within the sterile matrix under the human nail |
02/24/2005 | US20050043507 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis |
02/24/2005 | US20050042705 Methods for the identification of inhibitors of mannosyltransferase as antibiotics |
02/24/2005 | US20050042649 Arrayed biomolecules and their use in sequencing |
02/24/2005 | US20050042601 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
02/24/2005 | CA2535332A1 Method for rapid identification of alternative splicing |
02/24/2005 | CA2534729A1 Mitotic kinesin inhibitors |
02/24/2005 | CA2533924A1 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
02/24/2005 | CA2530748A1 Methylated gene biomarkers for detecting cancer |
02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
02/17/2005 | WO2005014850A2 Systems and methods for analyzing nucleic acid sequences |
02/17/2005 | WO2005014849A2 Genes associated with responses to neuropathic pain |
02/17/2005 | WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
02/17/2005 | WO2005014846A2 Methods for identifying risk of breast cancer and treatments thereof |
02/17/2005 | WO2004092396A3 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof |